Clinical Relevance of Serum Immunoglobulin A Antibodies to Epstein-Barr Virus Envelope Glycoprotein gp350 in Nasopharyngeal Carcinoma Patients
AUTOR(ES)
Xu, J. W.
FONTE
American Society for Microbiology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=105281Documentos Relacionados
- Monoclonal antibodies against the major glycoprotein (gp350/220) of Epstein-Barr virus neutralize infectivity.
- Epstein-Barr virus transcription in nasopharyngeal carcinoma.
- An Epstein-Barr Virus Isolated from a Lymphoblastoid Cell Line Has a 16-Kilobase-Pair Deletion Which Includes gp350 and the Epstein-Barr Virus Nuclear Antigen 3A
- Frequency and levels of antibodies to Epstein-Barr virus-specific DNase are elevated in patients with nasopharyngeal carcinoma.
- Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d.